<DOC>
	<DOCNO>NCT02245724</DOCNO>
	<brief_summary>The purpose study analyze benefit autologous mononuclear cell therapy mental retardation .</brief_summary>
	<brief_title>Stem Cell Therapy Mental Retardation</brief_title>
	<detailed_description />
	<mesh_term>Intellectual Disability</mesh_term>
	<criteria>diagnose case mental retardation age 6 month presence acute infection Human immunodeficiency virus/Hepatitis B Virus/Hepatitis C Virus malignancy bleed tendency pneumonia renal failure severe liver dysfunction severe anemia [ Hemoglobin &lt; 8 ] bone marrow disorder space occupy lesion brain acute medical condition respiratory infection pyrexia</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Mental retardation</keyword>
	<keyword>Autologous mononuclear cell therapy</keyword>
	<keyword>Stem cell</keyword>
</DOC>